Mesoblast Ltd. Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammato...
Mesoblast Ltd. ADR Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and in...
Ltd. to treat wound healing in patients with epidermolysis bullosa and for the treatment of neonatal hypoxic ischemic encephalopathy; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. The company was incorporated in 2004 and is headquartered in ...
Financial Results and Operational Update for the Period Ended June 30, 2024 E-mail Alerts Sign uphereto receive e-mail alerts. Tools Print Page RSS Feeds Email Alerts Share Price ASX: MSB.AX 2.24 as of Mar 21, 2025
Independent Research, Discussions, Filings, Analytics, SmartScore, Quant Rating and Latest News on Mesoblast Ltd (MSB AU, MSB.AX) - Mesoblast (MSB AU):...
Manufacturing Intellectual Property Scientific Publications Partnerships Overview Investors & Media At A Glance Company Announcements Share Price & Tools Events & Presentations Financial Information Shareholder Services Careers Current OpportunitiesCopyright © 2025 Mesoblast Ltd Disclaimer Privacy Policy Search ...
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases...